Insufficient evidence for low-dose CT lung CA screening

January 22, 2014
AAFP: insufficient evidence for low-dose CT lung CA screening

(HealthDay)—In contrast to a recommendation from the U.S. Preventive Services Task Force (USPSTF), the American Academy of Family Physicians (AAFP) has concluded that there is currently insufficient evidence to recommend screening for lung cancer with low-dose computed tomography (CT) among high-risk individuals.

Researchers from the AAFP expressed concern with the USPSTF recommendation, which was mainly based on the National Lung Screening Trial (NLST). Doug Campos-Outcalt, M.D., M.P.A., the AAFP liaison to the USPSTF, noted that the results of the other three trials included in the review failed to show the same magnitude of benefit as the NLST.

Furthermore, the study only conducted annual screening three times, but recommended screening for as long as individuals meet the criteria. Another consideration is that patients should be alerted to the fact that, although the annual CT screening scans may be covered with no copays or cost-sharing, follow-up testing may not be covered. Consequently the AAFP recommends shared decision-making between the clinician and patient and discussion of benefits and potential harms of screening.

"People need to understand that their could be extended by this, but on the other hand, their life expectancy could be shortened by it," Campos-Outcalt said in a statement. "If they're currently smoking, a better thing to do by far is to stop smoking."

Explore further: USPSTF: Evidence lacking for cognitive impairment screening

More information: More Information

Related Stories

USPSTF: Evidence lacking for cognitive impairment screening

November 5, 2013
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has found that the evidence is insufficient to assess the balance of benefits and harms of cognitive impairment screening for older adults without signs or symptoms ...

Final recommendations on lung cancer screening

December 30, 2013
High-risk adults between the ages of 55 and 80 should receive annual lung cancer screening with low-dose computed tomography, according to final recommendations from the U.S. Preventive Services Task Force being published ...

USPSTF updates recommendations on youth blood pressure screening

October 7, 2013
The United States Preventive Services Task Force (USPSTF) found insufficient evidence to recommend for or against routine screening for primary hypertension in asymptomatic children and adolescents. Hypertension in children ...

USPSTF: evidence lacking for ankle brachial index screening

September 3, 2013
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has found that there is currently insufficient evidence to weigh the benefits and harms of use of the ankle-brachial index (ABI) for screening for peripheral ...

American Cancer Society recommends informed decision making in lung cancer screening

January 11, 2013
New guidelines from the American Cancer Society say evidence is sufficient to recommend screening high risk patients for lung cancer with low-dose computed tomography (CT) provided that certain conditions exist:

USPSTF identifies high priority evidence gaps for older adults

November 20, 2013
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has produced their third annual report for Congress identifying high-priority evidence gaps specifically relating to the care of older adults.

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.